Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO
Go back to Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO| Regeneron (NASDAQ: REGN) | Delayed: 618.83 +6.33 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $612.50 | 52 Week High | $592.36 | |||
| Open | $607.92 | 52 Week Low | $325.35 | |||
| Day High | $621.79 | P/E | 162.42 | |||
| Day Low | $607.92 | EPS | $3.81 | |||
| Volume | 380,304 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 618.83 +6.33 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $612.50 | 52 Week High | $592.36 | |||
| Open | $607.92 | 52 Week Low | $325.35 | |||
| Day High | $621.79 | P/E | 162.42 | |||
| Day Low | $607.92 | EPS | $3.81 | |||
| Volume | 380,304 | |||||
